News Headlines

  1. Bristol-Myers Squibb And Nektar Therapeutics Announce Global Development & Commercialization Collaboration For Nektar’s CD122-Biased Agonist, NKTR-214
    2/14/2018

    Bristol-Myers Squibb Company and Nektar Therapeutics announced recently the companies have executed a global strategic development and commercialization collaboration for Nektar’s lead immuno-oncology program, NKTR-214.

  2. Celgene Unveils State-Of-The-Art Cellular Immunotherapy Manufacturing Facility
    2/12/2018

    Building on a long history of cellular therapy development and buoyed by the advancement of significant programs in cellular immunotherapy, Celgene completed the first phase of a renovation at its Summit West campus that will house a state-of-the-art cellular immunotherapy manufacturing center.

  3. ADC Bio Developing Downstream Bioconjugation Process
    2/12/2018

    ADC Biotechnology (ADC Bio) announces that it is developing a revolutionary, ‘downstream bioconjugation’ method that will present a new paradigm in Antibody Drug Conjugate (ADC) development and manufacturing.

  4. Seattle Genetics And Pieris Pharmaceuticals Announce Multi-Program Immuno-Oncology Collaboration
    2/9/2018

    Pieris Pharmaceuticals, Inc. a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for cancer, respiratory and other diseases, and Seattle Genetics, Inc. a global biotechnology company developing innovative, targeted therapies for cancer, recently announced they have entered into a collaboration and license agreement with the goal of developing multiple targeted bispecific immuno-oncology treatments for solid tumors and blood cancers.

  5. Catalent Recognized With 10 CMO Leadership Awards
    2/5/2018

    Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, recently announced it has won ten categories in the annual CMO Leadership Awards.

  6. Avara Pharmaceutical Services Wins Six CMO Leadership Awards Based On 3rd Party Research
    2/1/2018

    Avara Pharmaceutical Services, a world-class contract development and manufacturing organization (CDMO), has been informed that the company will receive awards in the six core categories of the 2018 Contract Manufacturing Organization "CMO" Awards based on industry ratings from a survey conducted for Life Science Leader magazine.

  7. Outsourced Pharma Announces Philadelphia Agenda
    2/1/2018

    Outsourced Pharma announces its Philadelphia agenda. Fundamentals for Outsourcing Drug Development and Manufacturing is scheduled for July 18 and 19, 2018 in Philadelphia.

  8. Seattle Genetics To Acquire Cascadian Therapeutics, Adding Late-Stage Breast Cancer Program To Its Oncology Pipeline
    1/31/2018

    Seattle Genetics, Inc. and Cascadian Therapeutics, Inc. recently announced the signing of a definitive merger agreement under which Seattle Genetics has agreed to acquire Cascadian Therapeutics.

  9. Agilent Partners With Science Exchange
    1/30/2018

    Agilent Technologies Inc. recently announced a partnership with Science Exchange, the world’s leading enterprise platform for outsourced research and development services

  10. Amazon, Berkshire Hathaway And JPMorgan Chase & Co. To Partner On U.S. Employee Healthcare
    1/30/2018

    Amazon, Berkshire Hathaway and JPMorgan Chase & Co. announced recently that they are partnering on ways to address healthcare for their U.S. employees, with the aim of improving employee satisfaction and reducing costs.